Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

Shares of Advanced Micro Devices, Inc. AMD shares rose sharply in today's pre-market trading following better-than-expected second-quarter earnings.

AMD reported quarterly earnings of 69 cents per share which beat the analyst consensus estimate of 68 cents per share. The company reported quarterly sales of $5.835 billion which beat the analyst consensus estimate of $5.724 billion, according to data from Benzinga Pro.

AMD shares jumped 9.1% to $151.01 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Primech Holdings Ltd. PMEC gained 114.8% to $1.13 in pre-market trading after gaining over 5% on Tuesday.
• Heramba Electric plc PITA shares climbed 92.8% to $8.29 in pre-market trading after dipping around 49% on Tuesday.
• NuZee, Inc. NUZE rose 79.4% to $6.64 in pre-market trading after gaining around 3% on Tuesday.
• Telesis Bio, Inc. TBIO gained 39.8% to $5.52 in pre-market trading.
• Faraday Future Intelligent Electric Inc. FFIE shares gained 33.1% to $0.4205 in pre-market trading after the company regained Nasdaq compliance.
• Powell Industries, Inc. POWL gained 25.3% to $167.02 in pre-market trading after posting better-than-expected third-quarter results.
• BIMI Holdings Inc. BIMI shares gained 22.8% to $0.48 in pre-market trading after dipping 66% on Tuesday.      
• DallasNews Corporation DALN shares gained 19.1% to $3.91 in pre-market trading after the company reported a year-over-year increase in second-quarter financial results.
• Vistra Corp. VST gained 12.1% to $77.35 in pre-market trading after the company announced that the Nuclear Regulatory Commission has approved its request to extend the operation of Comanche Peak Nuclear Power Plant through 2053.

Losers

• FibroGen, Inc. FGEN shares fell 40.2% to $0.6159 in pre-market trading. The company announced topline results from two late-stage trials evaluating the efficacy and safety of pamrevlumab in patients with pancreatic cancer and said its Precision Promise study in metastatic pancreatic cancer did not meet its primary endpoint.
• MacroGenics, Inc. MGNX shares declined 24% to $3.99 in pre-market trading. The company announced a presentation of clinical data from the TAMARACK Phase 2 study of vobramitamab duocarmazine at the upcoming European Society for Medical Oncology Congress 2024.
• Jet.AI Inc. JTAI fell 21.5% to $0.2631 in pre-market trading. Jet.AI announced expiration and successful results of exchange offer and consent solicitation relating to warrants.
• Velo3D, Inc. VLD shares fell 20.6% to $2.20 in pre-market trading after declining 4% on Tuesday.
• Penumbra, Inc. PEN shares fell 20.3% to $137.93 in pre-market trading after the company reported second-quarter financial results and cut its FY24 revenue guidance below estimates.
• Groupon, Inc. GRPN shares declined 18.6% to $12.75 in pre-market trading following a second-quarter EPS miss.
• Definitive Healthcare Corp. DH shares fell 17.6% to $4.71 in pre-market trading. Needham analyst Ryan MacDonald reiterated Definitive Healthcare with a Hold.
• O-I Glass, Inc. OI fell 15.5% to $9.80 in pre-market trading after the company lowered its FY24 guidance.
• Lemonade, Inc. LMND shares dipped 14.6% to $19.33 in pre-market trading following quarterly results.
• Tivic Health Systems, Inc. TIVC shares fell 12.4% to $0.5056 in pre-market trading after dipping 18% on Tuesday.

Now Read This:

• Nasdaq Tumbles As Microsoft, Nvidia And Other Tech Stocks Decline: Greed Index Moves To ‘Fear’ Zone